{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T12:23:22Z","timestamp":1793622202879,"version":"4.5.0"},"reference-count":290,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","award":["SRG\/2020\/001621"],"award-info":[{"award-number":["SRG\/2020\/001621"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.bbcan.2025.189471","type":"journal-article","created":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T12:59:06Z","timestamp":1760101146000},"page":"189471","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Mitochondrial dynamics and metabolic attributes regulate function of natural killer cell and infiltration in tumor microenvironment modulating disease progression"],"prefix":"10.1016","volume":"1880","author":[{"given":"Sayak","family":"Ghosh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rittick","family":"Dutta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devyani","family":"Goswami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debapriya","family":"Ghatak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudranil","family":"De","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.bbcan.2025.189471_bb0005","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.tem.2012.07.008","article-title":"The evolving role of mitochondria in metabolism","volume":"23","author":"Tzameli","year":"2012","journal-title":"Trends Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.bbcan.2025.189471_bb0010","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.molmed.2014.01.005","article-title":"Mitochondrial pathology: stress signals from the energy factory","volume":"20","author":"Raimundo","year":"2014","journal-title":"Trends Mol. Med."},{"issue":"4","key":"10.1016\/j.bbcan.2025.189471_bb0015","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.tibs.2020.11.007","article-title":"Mitochondrial dysfunction and Mitophagy in Parkinson\u2019s disease: from mechanism to therapy","volume":"46","author":"Malpartida","year":"2021","journal-title":"Trends Biochem. Sci."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189471_bb0020","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/1743-7075-10-63","article-title":"Mitochondrial-associated metabolic disorders: foundations, pathologies and recent progress","volume":"10","author":"McInnes","year":"2013","journal-title":"Nutr. Metab. (Lond.)"},{"issue":"10","key":"10.1016\/j.bbcan.2025.189471_bb0025","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/nrc3365","article-title":"Mitochondria and cancer","volume":"12","author":"Wallace","year":"2012","journal-title":"Nat. Rev. Cancer"},{"issue":"4","key":"10.1016\/j.bbcan.2025.189471_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.109384","article-title":"NSAID targets SIRT3 to trigger mitochondrial dysfunction and gastric cancer cell death","volume":"27","author":"Debsharma","year":"2024","journal-title":"iScience"},{"key":"10.1016\/j.bbcan.2025.189471_bb0035","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0070-2153(06)77005-3","article-title":"Mitochondrial disease--its impact, etiology, and pathology","volume":"77","author":"McFarland","year":"2007","journal-title":"Curr. Top. Dev. Biol."},{"issue":"6","key":"10.1016\/j.bbcan.2025.189471_bb0040","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1007\/s11010-022-04593-z","article-title":"Pathophysiological involvement of host mitochondria in SARS-CoV-2 infection that causes COVID-19: a comprehensive evidential insight","volume":"478","author":"Bhowal","year":"2023","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.bbcan.2025.189471_bb0045","series-title":"Proceedings of the International Conference on IoT Based Control Networks & Intelligent Systems-ICICNIS","article-title":"Role of the Internet of Things for Early Detection of Covid-19 Infections: a Comprehensive Survey","author":"Mondal","year":"2021"},{"issue":"3","key":"10.1016\/j.bbcan.2025.189471_bb0050","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1007\/s12013-024-01366-x","article-title":"A comprehensive Pan-Cancer analysis of cytochrome C oxidase assembly factor 1 (COA1) reveals instrumental role of mitochondrial protein assembly in Cancer that modulates disease progression and prognostic outcome","volume":"82","author":"Ghosh","year":"2024","journal-title":"Cell Biochem. Biophys."},{"issue":"45","key":"10.1016\/j.bbcan.2025.189471_bb0055","doi-asserted-by":"crossref","first-page":"5904","DOI":"10.1038\/onc.2008.271","article-title":"The tumor microenvironment and its role in promoting tumor growth","volume":"27","author":"Whiteside","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2025.189471_bb0060","doi-asserted-by":"crossref","DOI":"10.1007\/s12013-025-01857-5","article-title":"Multi-omics analysis implicates mitochondrial complex assembly protein COX18 in mitochondrial signaling and tumorigenesis across cancers","author":"Goswami","year":"2025","journal-title":"Cell Biochem. Biophys."},{"key":"10.1016\/j.bbcan.2025.189471_bb0065","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/978-3-030-49270-0_4","article-title":"NK cells in the tumor microenvironment","volume":"1273","author":"Guillerey","year":"2020","journal-title":"Adv. Exp. Med. Biol."},{"issue":"5","key":"10.1016\/j.bbcan.2025.189471_bb0070","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/s41577-019-0139-2","article-title":"Immunometabolism and natural killer cell responses","volume":"19","author":"O\u2019Brien","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bbcan.2025.189471_bb0075","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.872017","article-title":"Increased expression of mitochondrial UQCRC1 in pancreatic Cancer impairs antitumor immunity of natural killer cells via elevating extracellular ATP","volume":"12","author":"Cong","year":"2022","journal-title":"Front. Oncol."},{"issue":"12","key":"10.1016\/j.bbcan.2025.189471_bb0080","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15123225","article-title":"Enhancement of the anticancer ability of natural killer cells through allogeneic mitochondrial transfer","volume":"15","author":"Kim","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189471_bb0085","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s12943-020-01238-x","article-title":"Natural killer cells in cancer biology and therapy","volume":"19","author":"Wu","year":"2020","journal-title":"Mol. Cancer"},{"issue":"3","key":"10.1016\/j.bbcan.2025.189471_bb0090","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s00109-021-02120-z","article-title":"Unleashing the power of NK cells in anticancer immunotherapy","volume":"100","author":"Vogler","year":"2022","journal-title":"J. Mol. Med. (Berl)"},{"key":"10.1016\/j.bbcan.2025.189471_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2022.115369","article-title":"Immunometabolic attributes and mitochondria-associated signaling of tumor-associated macrophages in tumor microenvironment modulate cancer progression","volume":"208","author":"Dubey","year":"2023","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbcan.2025.189471_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2024.150268","article-title":"Immunometabolic characteristics of dendritic cells and its significant modulation by mitochondria-associated signaling in the tumor microenvironment influence cancer progression","volume":"726","author":"Ghosh","year":"2024","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbcan.2025.189471_bb0105","doi-asserted-by":"crossref","first-page":"1275028","DOI":"10.3389\/fimmu.2023.1275028","article-title":"Balancing act: the complex role of NK cells in immune regulation","volume":"14","author":"Jiang","year":"2023","journal-title":"Front. Immunol."},{"issue":"19","key":"10.1016\/j.bbcan.2025.189471_bb0110","doi-asserted-by":"crossref","first-page":"4235","DOI":"10.1016\/j.cell.2023.07.034","article-title":"A pan-cancer single-cell panorama of human natural killer cells","volume":"186","author":"Tang","year":"2023","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.bbcan.2025.189471_bb0115","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1002\/eji.201344072","article-title":"NK cells gain higher IFN-gamma competence during terminal differentiation","volume":"44","author":"Luetke-Eversloh","year":"2014","journal-title":"Eur. J. Immunol."},{"issue":"5","key":"10.1016\/j.bbcan.2025.189471_bb0120","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.immuni.2017.10.008","article-title":"The broad Spectrum of human natural killer cell diversity","volume":"47","author":"Freud","year":"2017","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189471_bb0125","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1158\/2159-8290.CD-20-0796","article-title":"Decidual-like NK cell polarization: from Cancer killing to Cancer nurturing","volume":"11","author":"Albini","year":"2021","journal-title":"Cancer Discov."},{"issue":"12","key":"10.1016\/j.bbcan.2025.189471_bb0130","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12123583","article-title":"An anti-MICA\/B antibody and IL-15 rescue altered NKG2D-dependent NK cell responses in hepatocellular carcinoma","volume":"12","author":"Mantovani","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"9","key":"10.1016\/j.bbcan.2025.189471_bb0135","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14092339","article-title":"Regulation of NKG2D stress ligands and its relevance in Cancer progression","volume":"14","author":"Jones","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbcan.2025.189471_bb0140","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.713158","article-title":"Leveraging NKG2D ligands in Immuno-oncology","volume":"12","author":"Fuertes","year":"2021","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.bbcan.2025.189471_bb0145","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.cell.2018.01.009","article-title":"CD10(+)GPR77(+) Cancer-associated fibroblasts promote Cancer formation and Chemoresistance by sustaining Cancer Stemness","volume":"172","author":"Su","year":"2018","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.bbcan.2025.189471_bb0150","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/ni.3482","article-title":"NK cells and type 1 innate lymphoid cells: partners in host defense","volume":"17","author":"Spits","year":"2016","journal-title":"Nat. Immunol."},{"issue":"7","key":"10.1016\/j.bbcan.2025.189471_bb0155","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.4049\/jimmunol.1502570","article-title":"Human CD56bright NK cells: an update","volume":"196","author":"Michel","year":"2016","journal-title":"J. Immunol."},{"issue":"8","key":"10.1016\/j.bbcan.2025.189471_bb0160","doi-asserted-by":"crossref","first-page":"4947","DOI":"10.4049\/jimmunol.178.8.4947","article-title":"CD56brightCD16- killer Ig-like receptor- NK cells display longer telomeres and acquire features of CD56dim NK cells upon activation","volume":"178","author":"Romagnani","year":"2007","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189471_bb0165","doi-asserted-by":"crossref","first-page":"12188","DOI":"10.1038\/s41598-024-63103-x","article-title":"Changes in subset distribution and impaired function of circulating natural killer cells in patients with colorectal cancer","volume":"14","author":"Zu","year":"2024","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.bbcan.2025.189471_bb0170","doi-asserted-by":"crossref","DOI":"10.15252\/embr.202154133","article-title":"Engagement of TRAIL triggers degranulation and IFNgamma production in human natural killer cells","volume":"23","author":"Hofle","year":"2022","journal-title":"EMBO Rep."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189471_bb0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41388-022-02562-w","article-title":"Metabolic hallmarks of natural killer cells in the tumor microenvironment and implications in cancer immunotherapy","volume":"42","author":"Yang","year":"2023","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2025.189471_bb0180","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2147\/ITT.S492334","article-title":"Adaptation of natural killer cells to hypoxia: a review of the transcriptional, translational, and metabolic processes","volume":"14","author":"Chang","year":"2025","journal-title":"Immunotargets Ther"},{"issue":"6","key":"10.1016\/j.bbcan.2025.189471_bb0185","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1038\/s41418-020-00715-6","article-title":"mTORC1 and mTORC2 coordinate early NK cell development by differentially inducing E4BP4 and T-bet","volume":"28","author":"Li","year":"2021","journal-title":"Cell Death Differ."},{"issue":"3","key":"10.1016\/j.bbcan.2025.189471_bb0190","doi-asserted-by":"crossref","DOI":"10.1111\/sji.12802","article-title":"Deficient glucose uptake is linked to impaired Glut1 expression upon CD3\/CD28 stimulation in memory T cells from pleural effusions secondary to lung cancer","volume":"90","author":"Prado-Garcia","year":"2019","journal-title":"Scand. J. Immunol."},{"issue":"12","key":"10.1016\/j.bbcan.2025.189471_bb0195","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1038\/s41590-019-0511-1","article-title":"Mitochondrial fragmentation limits NK cell-based tumor immunosurveillance","volume":"20","author":"Zheng","year":"2019","journal-title":"Nat. Immunol."},{"issue":"7","key":"10.1016\/j.bbcan.2025.189471_bb0200","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0201170","article-title":"Tissue-resident NK cells differ in their expression profile of the nutrient transporters Glut1, CD98 and CD71","volume":"13","author":"Salzberger","year":"2018","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.bbcan.2025.189471_bb0205","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1152\/physrev.00026.2020","article-title":"Regulation and metabolic functions of mTORC1 and mTORC2","volume":"101","author":"Szwed","year":"2021","journal-title":"Physiol. Rev."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189471_bb0210","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s13045-022-01349-6","article-title":"TGF-beta signaling in the tumor metabolic microenvironment and targeted therapies","volume":"15","author":"Shi","year":"2022","journal-title":"J. Hematol. Oncol."},{"issue":"26","key":"10.1016\/j.bbcan.2025.189471_bb0215","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.18632\/oncotarget.27654","article-title":"Renal cell tumors convert natural killer cells to a proangiogenic phenotype","volume":"11","author":"Guan","year":"2020","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.bbcan.2025.189471_bb0220","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.immuni.2018.09.009","article-title":"High-dimensional single-cell analysis identifies organ-specific signatures and conserved NK cell subsets in humans and mice","volume":"49","author":"Crinier","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.bbcan.2025.189471_bb0225","doi-asserted-by":"crossref","first-page":"699","DOI":"10.3389\/fimmu.2017.00699","article-title":"Human CD56(dim)CD16(dim) cells as an individualized natural killer cell subset","volume":"8","author":"Amand","year":"2017","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.bbcan.2025.189471_bb0230","first-page":"e332","article-title":"Response to comment on multifunctional human CD56low CD16low NK cells are the prominent subset in bone marrow of both pediatric healthy donors and leukemic patients","volume":"100","author":"Stabile","year":"2015","journal-title":"Haematologica"},{"issue":"6","key":"10.1016\/j.bbcan.2025.189471_bb0235","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/j.1600-0897.2009.00794.x","article-title":"The unique properties of uterine NK cells","volume":"63","author":"Manaster","year":"2010","journal-title":"Am. J. Reprod. Immunol."},{"issue":"9\u201310","key":"10.1016\/j.bbcan.2025.189471_bb0240","doi-asserted-by":"crossref","first-page":"352","DOI":"10.2119\/molmed.2009.00035","article-title":"Regulatory NK-cell functions in inflammation and autoimmunity","volume":"15","author":"Lunemann","year":"2009","journal-title":"Mol. Med."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189471_bb0245","doi-asserted-by":"crossref","DOI":"10.3390\/v14010046","article-title":"Expansion of CD56(dim)CD16(neg) NK cell subset and increased inhibitory KIRs in hospitalized COVID-19 patients","volume":"14","author":"Casado","year":"2021","journal-title":"Viruses"},{"issue":"4","key":"10.1016\/j.bbcan.2025.189471_bb0250","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/j.1365-2567.2008.03027.x","article-title":"CD56bright natural killer (NK) cells: an important NK cell subset","volume":"126","author":"Poli","year":"2009","journal-title":"Immunology"},{"issue":"8","key":"10.1016\/j.bbcan.2025.189471_bb0255","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/s41568-020-0272-z","article-title":"The cancer-natural killer cell immunity cycle","volume":"20","author":"Huntington","year":"2020","journal-title":"Nat. Rev. Cancer"},{"issue":"8","key":"10.1016\/j.bbcan.2025.189471_bb0260","doi-asserted-by":"crossref","first-page":"3805","DOI":"10.4049\/jimmunol.1301889","article-title":"CD56(bright)perforin(low) noncytotoxic human NK cells are abundant in both healthy and neoplastic solid tissues and recirculate to secondary lymphoid organs via afferent lymph","volume":"192","author":"Carrega","year":"2014","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.bbcan.2025.189471_bb0265","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1002\/cncr.23239","article-title":"Natural killer cells infiltrating human nonsmall-cell lung cancer are enriched in CD56 bright CD16(\u2212) cells and display an impaired capability to kill tumor cells","volume":"112","author":"Carrega","year":"2008","journal-title":"Cancer"},{"issue":"16","key":"10.1016\/j.bbcan.2025.189471_bb0270","doi-asserted-by":"crossref","first-page":"14360","DOI":"10.18632\/oncotarget.3965","article-title":"Highly effective NK cells are associated with good prognosis in patients with metastatic prostate cancer","volume":"6","author":"Pasero","year":"2015","journal-title":"Oncotarget"},{"issue":"9","key":"10.1016\/j.bbcan.2025.189471_bb0275","doi-asserted-by":"crossref","first-page":"3609","DOI":"10.1172\/JCI45816","article-title":"Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity","volume":"121","author":"Mamessier","year":"2011","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189471_bb0280","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1158\/0008-5472.CAN-13-1303","article-title":"Mature cytotoxic CD56(bright)\/CD16(+) natural killer cells can infiltrate lymph nodes adjacent to metastatic melanoma","volume":"74","author":"Messaoudene","year":"2014","journal-title":"Cancer Res."},{"issue":"18","key":"10.1016\/j.bbcan.2025.189471_bb0285","doi-asserted-by":"crossref","first-page":"8444","DOI":"10.1158\/0008-5472.CAN-06-4230","article-title":"The requirement for DNAM-1, NKG2D, and NKp46 in the natural killer cell-mediated killing of myeloma cells","volume":"67","author":"El-Sherbiny","year":"2007","journal-title":"Cancer Res."},{"issue":"16","key":"10.1016\/j.bbcan.2025.189471_bb0290","doi-asserted-by":"crossref","first-page":"5412","DOI":"10.1158\/0008-5472.CAN-10-4179","article-title":"Profound coordinated alterations of intratumoral NK cell phenotype and function in lung carcinoma","volume":"71","author":"Platonova","year":"2011","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.bbcan.2025.189471_bb0295","first-page":"2595","article-title":"Targeting CD137 enhances the efficacy of cetuximab","volume":"129","author":"Kohrt","year":"2019","journal-title":"J. Clin. Invest."},{"issue":"15","key":"10.1016\/j.bbcan.2025.189471_bb0300","doi-asserted-by":"crossref","first-page":"13835","DOI":"10.18632\/oncotarget.3453","article-title":"Characterization of tumor infiltrating natural killer cell subset","volume":"6","author":"Levi","year":"2015","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.bbcan.2025.189471_bb0305","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1593\/neo.121758","article-title":"The proangiogenic phenotype of natural killer cells in patients with non-small cell lung cancer","volume":"15","author":"Bruno","year":"2013","journal-title":"Neoplasia"},{"key":"10.1016\/j.bbcan.2025.189471_bb0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.biocel.2022.106311","article-title":"Role of CXCR3 in fibrotic tissue responses","volume":"152","author":"Wells","year":"2022","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"8","key":"10.1016\/j.bbcan.2025.189471_bb0315","doi-asserted-by":"crossref","first-page":"3939","DOI":"10.4049\/jimmunol.1202582","article-title":"Conversion of peripheral blood NK cells to a decidual NK-like phenotype by a cocktail of defined factors","volume":"190","author":"Cerdeira","year":"2013","journal-title":"J. Immunol."},{"issue":"10","key":"10.1016\/j.bbcan.2025.189471_bb0320","doi-asserted-by":"crossref","first-page":"3603","DOI":"10.1210\/jc.2012-1102","article-title":"Chemerin regulates NK cell accumulation and endothelial cell morphogenesis in the decidua during early pregnancy","volume":"97","author":"Carlino","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bbcan.2025.189471_bb0325","doi-asserted-by":"crossref","first-page":"5639","DOI":"10.1038\/ncomms6639","article-title":"Enrichment of CD56(dim)KIR + CD57 + highly cytotoxic NK cells in tumour-infiltrated lymph nodes of melanoma patients","volume":"5","author":"Ali","year":"2014","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.bbcan.2025.189471_bb0330","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.4049\/jimmunol.1200140","article-title":"Peripheral blood NK cells from breast cancer patients are tumor-induced composite subsets","volume":"190","author":"Mamessier","year":"2013","journal-title":"J. Immunol."},{"issue":"9","key":"10.1016\/j.bbcan.2025.189471_bb0335","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.3324\/haematol.2010.039743","article-title":"Blast-derived microvesicles in sera from patients with acute myeloid leukemia suppress natural killer cell function via membrane-associated transforming growth factor-beta1","volume":"96","author":"Szczepanski","year":"2011","journal-title":"Haematologica"},{"issue":"6","key":"10.1016\/j.bbcan.2025.189471_bb0340","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1002\/ijc.25791","article-title":"Elevated frequencies of CD4(+) CD25(+) CD127lo regulatory T cells is associated to poor prognosis in patients with acute myeloid leukemia","volume":"129","author":"Shenghui","year":"2011","journal-title":"Int. J. Cancer"},{"issue":"4","key":"10.1016\/j.bbcan.2025.189471_bb0345","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1038\/leu.2015.327","article-title":"The TGF-beta\/SMAD pathway is an important mechanism for NK cell immune evasion in childhood B-acute lymphoblastic leukemia","volume":"30","author":"Rouce","year":"2016","journal-title":"Leukemia"},{"issue":"8","key":"10.1016\/j.bbcan.2025.189471_bb0350","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1002\/eji.200939910","article-title":"TGF-beta affects development and differentiation of human natural killer cell subsets","volume":"40","author":"Allan","year":"2010","journal-title":"Eur. J. Immunol."},{"issue":"9","key":"10.1016\/j.bbcan.2025.189471_bb0355","doi-asserted-by":"crossref","first-page":"3378","DOI":"10.1073\/pnas.0611098104","article-title":"TGFbeta promotes conversion of CD16+ peripheral blood NK cells into CD16- NK cells with similarities to decidual NK cells","volume":"104","author":"Keskin","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"10","key":"10.1016\/j.bbcan.2025.189471_bb0360","doi-asserted-by":"crossref","first-page":"5321","DOI":"10.4049\/jimmunol.1202693","article-title":"Neuroblastoma-derived TGF-beta1 modulates the chemokine receptor repertoire of human resting NK cells","volume":"190","author":"Castriconi","year":"2013","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.bbcan.2025.189471_bb0365","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/ni.3704","article-title":"Mitochondria are the powerhouses of immunity","volume":"18","author":"Mills","year":"2017","journal-title":"Nat. Immunol."},{"issue":"3","key":"10.1016\/j.bbcan.2025.189471_bb0370","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s10565-020-09561-1","article-title":"Mediators of mitophagy that regulate mitochondrial quality control play crucial role in diverse pathophysiology","volume":"37","author":"De","year":"2021","journal-title":"Cell Biol. Toxicol."},{"key":"10.1016\/j.bbcan.2025.189471_bb0375","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2019.101255","article-title":"Mitochondria as central hub of the immune system","volume":"26","author":"Breda","year":"2019","journal-title":"Redox Biol."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189471_bb0380","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.it.2017.08.006","article-title":"Mitochondrial dynamics at the Interface of immune cell metabolism and function","volume":"39","author":"Rambold","year":"2018","journal-title":"Trends Immunol."},{"issue":"7631","key":"10.1016\/j.bbcan.2025.189471_bb0385","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/nature20555","article-title":"Multiple dynamin family members collaborate to drive mitochondrial division","volume":"540","author":"Lee","year":"2016","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189471_bb0390","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.cell.2013.08.032","article-title":"Mitochondrial cristae shape determines respiratory chain supercomplexes assembly and respiratory efficiency","volume":"155","author":"Cogliati","year":"2013","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189471_bb0395","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1182\/bloodadvances.2020003458","article-title":"Polarized mitochondria as guardians of NK cell fitness","volume":"5","author":"Surace","year":"2021","journal-title":"Blood Adv."},{"issue":"6","key":"10.1016\/j.bbcan.2025.189471_bb0400","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.cmet.2021.03.023","article-title":"Metabolic flexibility determines human NK cell functional fate in the tumor microenvironment","volume":"33","author":"Poznanski","year":"2021","journal-title":"Cell Metab."},{"issue":"2","key":"10.1016\/j.bbcan.2025.189471_bb0405","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-002044","article-title":"TGFbeta drives NK cell metabolic dysfunction in human metastatic breast cancer","volume":"9","author":"Slattery","year":"2021","journal-title":"J. Immunother. Cancer"},{"issue":"8","key":"10.1016\/j.bbcan.2025.189471_bb0410","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1007\/s00262-020-02561-4","article-title":"Energy metabolism and cell motility defect in NK-cells from patients with hepatocellular carcinoma","volume":"69","author":"Zecca","year":"2020","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.bbcan.2025.189471_bb0415","doi-asserted-by":"crossref","first-page":"1004871","DOI":"10.3389\/fonc.2022.1004871","article-title":"Heightened metabolic responses in NK cells from patients with neuroblastoma suggests increased potential for immunotherapy","volume":"12","author":"Slattery","year":"2022","journal-title":"Front. Oncol."},{"issue":"7","key":"10.1016\/j.bbcan.2025.189471_bb0420","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-004825","article-title":"ELK3 modulates the antitumor efficacy of natural killer cells against triple negative breast cancer by regulating mitochondrial dynamics","volume":"10","author":"Park","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.bbcan.2025.189471_bb0425","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2024.110110","article-title":"PINK1 insufficiency can be exploited as a specific target for drug combinations inducing mitochondrial pathology-mediated cell death in gastric adenocarcinoma","volume":"759","author":"Ghosh","year":"2024","journal-title":"Arch. Biochem. Biophys."},{"issue":"7","key":"10.1016\/j.bbcan.2025.189471_bb0430","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/s41423-020-0480-1","article-title":"The essential functions of mitochondrial dynamics in immune cells","volume":"17","author":"Xie","year":"2020","journal-title":"Cell. Mol. Immunol."},{"issue":"9","key":"10.1016\/j.bbcan.2025.189471_bb0435","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/j.cell.2022.03.030","article-title":"Augmenting NK cell-based immunotherapy by targeting mitochondrial apoptosis","volume":"185","author":"Pan","year":"2022","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.bbcan.2025.189471_bb0440","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1002\/hep.27312","article-title":"Reciprocal activation between ATPase inhibitory factor 1 and NF-kappaB drives hepatocellular carcinoma angiogenesis and metastasis","volume":"60","author":"Song","year":"2014","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.bbcan.2025.189471_bb0445","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1159\/000439027","article-title":"Silencing of ATPase inhibitory factor 1 inhibits cell growth via cell cycle arrest in bladder Cancer","volume":"82","author":"Wei","year":"2015","journal-title":"Pathobiology"},{"issue":"4","key":"10.1016\/j.bbcan.2025.189471_bb0450","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.3892\/ol.2015.3548","article-title":"ATPase inhibitory factor 1 is a potential prognostic marker for the migration and invasion of glioma","volume":"10","author":"Wu","year":"2015","journal-title":"Oncol. Lett."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189471_bb0455","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12010022","article-title":"Overexpression of mitochondrial IF1 prevents metastatic disease of colorectal Cancer by enhancing Anoikis and tumor infiltration of NK cells","volume":"12","author":"Gonzalez-Llorente","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbcan.2025.189471_bb0460","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.176106","article-title":"The effect of mitochondria inhibition on natural killer cells cytotoxicity in triple-negative breast cancer cells","volume":"960","author":"Hossenipour Khodaei","year":"2023","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189471_bb0465","doi-asserted-by":"crossref","first-page":"38","DOI":"10.20892\/j.issn.2095-3941.2018.0253","article-title":"The PI3K\/Akt\/GSK-3beta\/ROS\/eIF2B pathway promotes breast cancer growth and metastasis via suppression of NK cell cytotoxicity and tumor cell susceptibility","volume":"16","author":"Jin","year":"2019","journal-title":"Cancer Biol. Med."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189471_bb0470","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/s41392-022-01126-4","article-title":"Mitochondrial apoptosis: facilitator of NK cell-mediated immunotherapy","volume":"7","author":"Ullrich","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189471_bb0475","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41392-024-01757-9","article-title":"NF-kappaB in biology and targeted therapy: new insights and translational implications","volume":"9","author":"Guo","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"issue":"5","key":"10.1016\/j.bbcan.2025.189471_bb0480","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1038\/cdd.2014.180","article-title":"Granzyme B-induced mitochondrial ROS are required for apoptosis","volume":"22","author":"Jacquemin","year":"2015","journal-title":"Cell Death Differ."},{"issue":"4","key":"10.1016\/j.bbcan.2025.189471_bb0485","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.4049\/jimmunol.134.4.2637","article-title":"Natural killer cell-mediated lysis involves an hydroxyl radical-dependent step","volume":"134","author":"Duwe","year":"1985","journal-title":"J. Immunol."},{"issue":"18","key":"10.1016\/j.bbcan.2025.189471_bb0490","doi-asserted-by":"crossref","first-page":"5543","DOI":"10.7150\/jca.54699","article-title":"Dual role of reactive oxygen species and their application in Cancer therapy","volume":"12","author":"Huang","year":"2021","journal-title":"J. Cancer"},{"issue":"7","key":"10.1016\/j.bbcan.2025.189471_bb0495","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12071748","article-title":"Reactive oxygen species and antitumor immunity-from surveillance to evasion","volume":"12","author":"Kotsafti","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbcan.2025.189471_bb0500","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.freeradbiomed.2017.10.009","article-title":"Acute mental stress induces mitochondrial bioenergetic crisis and hyper-fission along with aberrant mitophagy in the gut mucosa in rodent model of stress-related mucosal disease","volume":"113","author":"De","year":"2017","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bbcan.2025.189471_bb0505","doi-asserted-by":"crossref","first-page":"1243613","DOI":"10.3389\/fphar.2023.1243613","article-title":"The mechanisms of action of mitochondrial targeting agents in cancer: inhibiting oxidative phosphorylation and inducing apoptosis","volume":"14","author":"Yang","year":"2023","journal-title":"Front. Pharmacol."},{"issue":"7","key":"10.1016\/j.bbcan.2025.189471_bb0510","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/j.bbamcr.2012.11.016","article-title":"Calcium, cancer and killing: the role of calcium in killing cancer cells by cytotoxic T lymphocytes and natural killer cells","volume":"1833","author":"Schwarz","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbcan.2025.189471_bb0515","doi-asserted-by":"crossref","first-page":"12109","DOI":"10.1038\/ncomms12109","article-title":"MCOLN1 is a ROS sensor in lysosomes that regulates autophagy","volume":"7","author":"Zhang","year":"2016","journal-title":"Nat. Commun."},{"issue":"12","key":"10.1016\/j.bbcan.2025.189471_bb0520","doi-asserted-by":"crossref","DOI":"10.3390\/cells9122682","article-title":"TRPML1-emerging roles in Cancer","volume":"9","author":"Yang","year":"2020","journal-title":"Cells"},{"issue":"9","key":"10.1016\/j.bbcan.2025.189471_bb0525","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.4049\/jimmunol.2300406","article-title":"The lysosomal Calcium Channel TRPML1 maintains mitochondrial fitness in NK cells through Interorganelle cross-talk","volume":"211","author":"Clement","year":"2023","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbcan.2025.189471_bb0530","doi-asserted-by":"crossref","first-page":"8371","DOI":"10.1038\/ncomms9371","article-title":"Regulation of NKT cell-mediated immune responses to tumours and liver inflammation by mitochondrial PGAM5-Drp1 signalling","volume":"6","author":"Kang","year":"2015","journal-title":"Nat. Commun."},{"issue":"10","key":"10.1016\/j.bbcan.2025.189471_bb0535","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2020.165845","article-title":"Mitochondrial function in immune cells in health and disease","volume":"1866","author":"Faas","year":"2020","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"key":"10.1016\/j.bbcan.2025.189471_bb0540","doi-asserted-by":"crossref","first-page":"1045624","DOI":"10.3389\/fimmu.2022.1045624","article-title":"Tumor-derived extracellular vesicles modulate innate immune responses to affect tumor progression","volume":"13","author":"Wang","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2025.189471_bb0545","doi-asserted-by":"crossref","first-page":"482","DOI":"10.3389\/fimmu.2015.00482","article-title":"Critical role of tumor microenvironment in shaping NK cell functions: implication of hypoxic stress","volume":"6","author":"Hasmim","year":"2015","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.bbcan.2025.189471_bb0550","doi-asserted-by":"crossref","first-page":"138","DOI":"10.21147\/j.issn.1000-9604.2024.02.04","article-title":"Hypoxic tumor microenvironment: destroyer of natural killer cell function","volume":"36","author":"Zhang","year":"2024","journal-title":"Chin. J. Cancer Res."},{"key":"10.1016\/j.bbcan.2025.189471_bb0555","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.910595","article-title":"Underlying mechanisms of evasion from NK cells as rationale for improvement of NK cell-based immunotherapies","volume":"13","author":"Seliger","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2025.189471_bb0560","doi-asserted-by":"crossref","first-page":"490","DOI":"10.3389\/fimmu.2013.00490","article-title":"The critical role of the tumor microenvironment in shaping natural killer cell-mediated anti-tumor immunity","volume":"4","author":"Baginska","year":"2013","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.bbcan.2025.189471_bb0565","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/j.yexcr.2010.02.045","article-title":"Hallmarks of cancer: interactions with the tumor stroma","volume":"316","author":"Pietras","year":"2010","journal-title":"Exp. Cell Res."},{"issue":"10","key":"10.1016\/j.bbcan.2025.189471_bb0570","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.2337\/db15-1723","article-title":"TGF-beta contributes to impaired exercise response by suppression of mitochondrial key regulators in skeletal muscle","volume":"65","author":"Bohm","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/j.bbcan.2025.189471_bb0575","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3389\/fimmu.2020.00311","article-title":"NK cell function regulation by TGF-beta-induced epigenetic mechanisms","volume":"11","author":"Regis","year":"2020","journal-title":"Front. Immunol."},{"issue":"415","key":"10.1016\/j.bbcan.2025.189471_bb0580","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aad1884","article-title":"TGF-beta inhibits the activation and functions of NK cells by repressing the mTOR pathway","volume":"9","author":"Viel","year":"2016","journal-title":"Sci. Signal."},{"key":"10.1016\/j.bbcan.2025.189471_bb0585","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.3389\/fimmu.2019.02915","article-title":"NK cell metabolism and TGFbeta - implications for immunotherapy","volume":"10","author":"Slattery","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2025.189471_bb0590","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcmd.2020.102488","article-title":"IFN-gamma directly inhibits the activity of erythropoietin in human erythroid progenitors","volume":"85","author":"Araki","year":"2020","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.bbcan.2025.189471_bb0595","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114356","article-title":"Overcoming interferon (IFN)-gamma resistance ameliorates transforming growth factor (TGF)-beta-mediated lung fibroblast-to-myofibroblast transition and bleomycin-induced pulmonary fibrosis","volume":"183","author":"Chang","year":"2021","journal-title":"Biochem. Pharmacol."},{"issue":"8011","key":"10.1016\/j.bbcan.2025.189471_bb0600","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/s41586-024-07352-w","article-title":"PGE(2) inhibits TIL expansion by disrupting IL-2 signalling and mitochondrial function","volume":"629","author":"Morotti","year":"2024","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.bbcan.2025.189471_bb0605","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.immuni.2018.10.011","article-title":"Mitochondrial membrane potential regulates nuclear gene expression in macrophages exposed to prostaglandin E2","volume":"49","author":"Sanin","year":"2018","journal-title":"Immunity"},{"issue":"10","key":"10.1016\/j.bbcan.2025.189471_bb0610","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S1471-4906(01)02005-1","article-title":"IFN-gamma production by antigen-presenting cells: mechanisms emerge","volume":"22","author":"Frucht","year":"2001","journal-title":"Trends Immunol."},{"issue":"2","key":"10.1016\/j.bbcan.2025.189471_bb0615","doi-asserted-by":"crossref","DOI":"10.1002\/eji.202350635","article-title":"Prostaglandin E(2) impacts multiple stages of the natural killer cell antitumor immune response","volume":"54","author":"Patterson","year":"2024","journal-title":"Eur. J. Immunol."},{"issue":"2","key":"10.1016\/j.bbcan.2025.189471_bb0620","doi-asserted-by":"crossref","first-page":"885","DOI":"10.4049\/jimmunol.166.2.885","article-title":"Prostaglandin E2 suppressed IL-15-mediated human NK cell function through down-regulation of common gamma-chain","volume":"166","author":"Joshi","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbcan.2025.189471_bb0625","doi-asserted-by":"crossref","first-page":"1303605","DOI":"10.3389\/fimmu.2023.1303605","article-title":"NK cell exhaustion in the tumor microenvironment","volume":"14","author":"Jia","year":"2023","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189471_bb0630","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1186\/s12967-024-05033-w","article-title":"Advances in metabolic reprogramming of NK cells in the tumor microenvironment on the impact of NK therapy","volume":"22","author":"Miao","year":"2024","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.bbcan.2025.189471_bb0635","doi-asserted-by":"crossref","first-page":"1453886","DOI":"10.3389\/fimmu.2024.1453886","article-title":"Mitochondrial regulation in the tumor microenvironment: targeting mitochondria for immunotherapy","volume":"15","author":"Ahn","year":"2024","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.bbcan.2025.189471_bb0640","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/BF02536139","article-title":"31P NMR of tissue phospholipids: competition for Mg2+, Ca2+, Na+ and K+ cations","volume":"27","author":"Merchant","year":"1992","journal-title":"Lipids"},{"issue":"4","key":"10.1016\/j.bbcan.2025.189471_bb0645","first-page":"R509","article-title":"IL-6 induces mitochondrial ROS production and blunts NO bioavailability in human aortic endothelial cells","volume":"328","author":"Velusamy","year":"2025","journal-title":"Am. J. Phys. Regul. Integr. Comp. Phys."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189471_bb0650","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s40364-025-00784-0","article-title":"The progress and prospects of targeting the adenosine pathway in cancer immunotherapy","volume":"13","author":"Yang","year":"2025","journal-title":"Biomark. Res."},{"issue":"13","key":"10.1016\/j.bbcan.2025.189471_bb0655","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1007\/s00018-019-03438-1","article-title":"Melatonin inhibits Warburg-dependent cancer by redirecting glucose oxidation to the mitochondria: a mechanistic hypothesis","volume":"77","author":"Reiter","year":"2020","journal-title":"Cell. Mol. Life Sci."},{"issue":"6","key":"10.1016\/j.bbcan.2025.189471_bb0660","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1084\/jem.20102555","article-title":"Innate and cytokine-driven signals, rather than microbial antigens, dominate in natural killer T cell activation during microbial infection","volume":"208","author":"Brigl","year":"2011","journal-title":"J. Exp. Med."},{"issue":"3","key":"10.1016\/j.bbcan.2025.189471_bb0665","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2016.1274478","article-title":"IL-12, IL-15, and IL-18 pre-activated NK cells target resistant T cell acute lymphoblastic leukemia and delay leukemia development in vivo","volume":"6","author":"Boieri","year":"2017","journal-title":"Oncoimmunology"},{"issue":"3","key":"10.1016\/j.bbcan.2025.189471_bb0670","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.ccell.2018.02.005","article-title":"Tumor-repopulating cells induce PD-1 expression in CD8(+) T cells by transferring kynurenine and AhR activation","volume":"33","author":"Liu","year":"2018","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189471_bb0675","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1186\/s13287-021-02377-8","article-title":"Optimising NK cell metabolism to increase the efficacy of cancer immunotherapy","volume":"12","author":"Choi","year":"2021","journal-title":"Stem Cell Res Ther"},{"issue":"13","key":"10.1016\/j.bbcan.2025.189471_bb0680","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1084\/jem.20120944","article-title":"Sustained effector function of IL-12\/15\/18-preactivated NK cells against established tumors","volume":"209","author":"Ni","year":"2012","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189471_bb0685","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s13046-023-02629-w","article-title":"L-kynurenine induces NK cell loss in gastric cancer microenvironment via promoting ferroptosis","volume":"42","author":"Cui","year":"2023","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2025.189471_bb0690","doi-asserted-by":"crossref","DOI":"10.1016\/j.jri.2020.103270","article-title":"Kynurenine promotes the cytotoxicity of NK cells through aryl hydrocarbon receptor in early pregnancy","volume":"143","author":"Yang","year":"2021","journal-title":"J. Reprod. Immunol."},{"key":"10.1016\/j.bbcan.2025.189471_bb0695","doi-asserted-by":"crossref","first-page":"1524651","DOI":"10.3389\/fonc.2024.1524651","article-title":"Targeting the kynurenine pathway: another therapeutic opportunity in the metabolic crosstalk between cancer and immune cells","volume":"14","author":"Kang","year":"2024","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbcan.2025.189471_bb0700","first-page":"673","article-title":"Cancer immunotherapy by targeting IDO1\/TDO and their downstream effectors","volume":"5","author":"Platten","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2025.189471_bb0705","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106132","article-title":"IDO1 can impair NK cells function against non-small cell lung cancer by downregulation of NKG2D ligand via ADAM10","volume":"177","author":"Fang","year":"2022","journal-title":"Pharmacol. Res."},{"issue":"30","key":"10.1016\/j.bbcan.2025.189471_bb0710","doi-asserted-by":"crossref","first-page":"12391","DOI":"10.1073\/pnas.1302856110","article-title":"Modulation of natural killer cell antitumor activity by the aryl hydrocarbon receptor","volume":"110","author":"Shin","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"13","key":"10.1016\/j.bbcan.2025.189471_bb0715","doi-asserted-by":"crossref","first-page":"4118","DOI":"10.1182\/blood-2006-03-006700","article-title":"The tryptophan catabolite L-kynurenine inhibits the surface expression of NKp46- and NKG2D-activating receptors and regulates NK-cell function","volume":"108","author":"Della Chiesa","year":"2006","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189471_bb0720","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/s41392-024-02005-w","article-title":"Comprehensive snapshots of natural killer cells functions, signaling, molecular mechanisms and clinical utilization","volume":"9","author":"Chen","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"issue":"22","key":"10.1016\/j.bbcan.2025.189471_bb0725","doi-asserted-by":"crossref","first-page":"4605","DOI":"10.1182\/bloodadvances.2021004533","article-title":"Defining the AHR-regulated transcriptome in NK cells reveals gene expression programs relevant to development and function","volume":"5","author":"Trikha","year":"2021","journal-title":"Blood Adv."},{"issue":"13","key":"10.1016\/j.bbcan.2025.189471_bb0730","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25136933","article-title":"Kynurenic acid\/AhR signaling at the junction of inflammation and cardiovascular diseases","volume":"25","author":"Grishanova","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189471_bb0735","doi-asserted-by":"crossref","DOI":"10.3390\/molecules23010191","article-title":"Mitochondria, oxidative stress and the kynurenine system, with a focus on ageing and neuroprotection","volume":"23","author":"Sas","year":"2018","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/j.bbcan.2025.189471_bb0740","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25031698","article-title":"Kynurenines, neuronal excitotoxicity, and mitochondrial oxidative stress: role of the intestinal Flora","volume":"25","author":"Nagy-Grocz","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.bbcan.2025.189471_bb0745","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1615\/CritRevImmunol.2016017387","article-title":"Metabolic regulation of natural killer cell IFN-gamma production","volume":"36","author":"Mah","year":"2016","journal-title":"Crit. Rev. Immunol."},{"key":"10.1016\/j.bbcan.2025.189471_bb0750","doi-asserted-by":"crossref","first-page":"1256769","DOI":"10.3389\/fonc.2023.1256769","article-title":"The kynurenine pathway presents multi-faceted metabolic vulnerabilities in cancer","volume":"13","author":"Leon-Letelier","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbcan.2025.189471_bb0755","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.678999","article-title":"IDO1 expression in ovarian Cancer induces PD-1 in T cells via aryl hydrocarbon receptor activation","volume":"12","author":"Amobi-McCloud","year":"2021","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189471_bb0760","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s13045-018-0644-y","article-title":"Targeting the IDO1 pathway in cancer: from bench to bedside","volume":"11","author":"Liu","year":"2018","journal-title":"J. Hematol. Oncol."},{"issue":"11","key":"10.1016\/j.bbcan.2025.189471_bb0765","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15112895","article-title":"Interactions of IDO and the kynurenine pathway with cell transduction systems and metabolism at the inflammation-Cancer Interface","volume":"15","author":"Stone","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"3","key":"10.1016\/j.bbcan.2025.189471_bb0770","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.tips.2017.11.007","article-title":"Targeting the IDO1\/TDO2-KYN-AhR pathway for Cancer immunotherapy - challenges and opportunities","volume":"39","author":"Cheong","year":"2018","journal-title":"Trends Pharmacol. Sci."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189471_bb0775","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/s41420-024-02006-2","article-title":"Immunometabolism in cancer: basic mechanisms and new targeting strategy","volume":"10","author":"Su","year":"2024","journal-title":"Cell Death Dis."},{"issue":"11","key":"10.1016\/j.bbcan.2025.189471_bb0780","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/s41577-018-0061-z","article-title":"Natural killer cells and other innate lymphoid cells in cancer","volume":"18","author":"Chiossone","year":"2018","journal-title":"Nat. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.bbcan.2025.189471_bb0785","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/s42255-020-0174-0","article-title":"Cholesterol metabolism in cancer: mechanisms and therapeutic opportunities","volume":"2","author":"Huang","year":"2020","journal-title":"Nat. Metab."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189471_bb0790","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s40880-018-0301-4","article-title":"Lipid metabolism reprogramming and its potential targets in cancer","volume":"38","author":"Cheng","year":"2018","journal-title":"Cancer Commun (Lond)"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189471_bb0795","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s12026-024-09573-7","volume":"73","author":"Esen","year":"2024","journal-title":"Immunol. Res."},{"key":"10.1016\/j.bbcan.2025.189471_bb0800","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.849962","article-title":"Mitochondrial fission and fusion in tumor progression to metastasis","volume":"10","author":"Boulton","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.bbcan.2025.189471_bb0805","article-title":"Powering immunity: mitochondrial dynamics in natural killer cells","author":"Verhezen","year":"2025","journal-title":"Trends Mol. Med."},{"issue":"48","key":"10.1016\/j.bbcan.2025.189471_bb0810","doi-asserted-by":"crossref","first-page":"45208","DOI":"10.1021\/acsomega.3c06547","article-title":"DRP1: at the crossroads of dysregulated mitochondrial dynamics and altered cell signaling in Cancer cells","volume":"8","author":"Adhikary","year":"2023","journal-title":"ACS Omega"},{"key":"10.1016\/j.bbcan.2025.189471_bb0815","doi-asserted-by":"crossref","first-page":"1112222","DOI":"10.3389\/fcvm.2023.1112222","article-title":"Role of mitochondrial metabolism in immune checkpoint inhibitors-related myocarditis","volume":"10","author":"Zhang","year":"2023","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.bbcan.2025.189471_bb0820","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216223","article-title":"Mitochondrial immune regulation and anti-tumor immunotherapy strategies targeting mitochondria","volume":"564","author":"Bai","year":"2023","journal-title":"Cancer Lett."},{"issue":"9","key":"10.1016\/j.bbcan.2025.189471_bb0825","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2020.101454","article-title":"Conditional deletion of PGC-1alpha results in energetic and functional defects in NK cells","volume":"23","author":"Gerbec","year":"2020","journal-title":"iScience"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189471_bb0830","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1186\/s12943-024-02175-9","article-title":"Targeting mitochondria: restoring the antitumor efficacy of exhausted T cells","volume":"23","author":"Yang","year":"2024","journal-title":"Mol. Cancer"},{"issue":"16\u201318","key":"10.1016\/j.bbcan.2025.189471_bb0835","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1089\/ars.2021.0215","article-title":"Kynurenine\/aryl hydrocarbon receptor modulates mitochondria-mediated oxidative stress and neuronal apoptosis in experimental intracerebral hemorrhage","volume":"37","author":"Ren","year":"2022","journal-title":"Antioxid. Redox Signal."},{"issue":"11","key":"10.1016\/j.bbcan.2025.189471_bb0840","doi-asserted-by":"crossref","first-page":"8133","DOI":"10.3390\/curroncol29110642","article-title":"CD36 and its role in regulating the tumor microenvironment","volume":"29","author":"Liao","year":"2022","journal-title":"Curr. Oncol."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189471_bb0845","doi-asserted-by":"crossref","first-page":"5782","DOI":"10.1038\/s41467-022-33349-y","article-title":"CD36-mediated metabolic crosstalk between tumor cells and macrophages affects liver metastasis","volume":"13","author":"Yang","year":"2022","journal-title":"Nat. Commun."},{"issue":"26","key":"10.1016\/j.bbcan.2025.189471_bb0850","doi-asserted-by":"crossref","first-page":"3004","DOI":"10.1182\/blood.2020005602","article-title":"Increased lipid metabolism impairs NK cell function and mediates adaptation to the lymphoma environment","volume":"136","author":"Kobayashi","year":"2020","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189471_bb0855","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23010164","article-title":"Challenges and recent advances in NK cell-targeted immunotherapies in solid tumors","volume":"23","author":"Lian","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189471_bb0860","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s12943-025-02407-6","article-title":"Metabolic checkpoints in immune cell reprogramming: rewiring immunometabolism for cancer therapy","volume":"24","author":"Lv","year":"2025","journal-title":"Mol. Cancer"},{"issue":"5","key":"10.1016\/j.bbcan.2025.189471_bb0865","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.immuni.2016.05.001","article-title":"Lag-3, Tim-3, and TIGIT: co-inhibitory receptors with specialized functions in immune regulation","volume":"44","author":"Anderson","year":"2016","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189471_bb0870","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s43556-025-00267-6","article-title":"TIM-3 teams up with PD-1 in cancer immunotherapy: mechanisms and perspectives","volume":"6","author":"Yan","year":"2025","journal-title":"Mol Biomed"},{"issue":"6","key":"10.1016\/j.bbcan.2025.189471_bb0875","doi-asserted-by":"crossref","DOI":"10.3390\/cells10061420","article-title":"NKG2D natural killer cell receptor-a short description and potential clinical applications","volume":"10","author":"Siemaszko","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.bbcan.2025.189471_bb0880","doi-asserted-by":"crossref","first-page":"441","DOI":"10.3389\/fimmu.2018.00441","article-title":"NKG2D: a master regulator of immune cell responsiveness","volume":"9","author":"Wensveen","year":"2018","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.bbcan.2025.189471_bb0885","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1002\/JLB.MR0718-260R","article-title":"NK cell metabolism","volume":"105","author":"Gardiner","year":"2019","journal-title":"J. Leukoc. Biol."},{"issue":"8","key":"10.1016\/j.bbcan.2025.189471_bb0890","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/ni.2936","article-title":"The metabolic checkpoint kinase mTOR is essential for IL-15 signaling during the development and activation of NK cells","volume":"15","author":"Marcais","year":"2014","journal-title":"Nat. Immunol."},{"issue":"43","key":"10.1016\/j.bbcan.2025.189471_bb0895","doi-asserted-by":"crossref","first-page":"17450","DOI":"10.1073\/pnas.1304790110","article-title":"Granzyme B degradation by autophagy decreases tumor cell susceptibility to natural killer-mediated lysis under hypoxia","volume":"110","author":"Baginska","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189471_bb0900","doi-asserted-by":"crossref","first-page":"173","DOI":"10.4161\/auto.26924","article-title":"Autophagic degradation of GZMB\/granzyme B: a new mechanism of hypoxic tumor cell escape from natural killer cell-mediated lysis","volume":"10","author":"Viry","year":"2014","journal-title":"Autophagy"},{"key":"10.1016\/j.bbcan.2025.189471_bb0905","doi-asserted-by":"crossref","first-page":"887","DOI":"10.3389\/fimmu.2018.00887","article-title":"Targeting autophagy in the tumor microenvironment: new challenges and opportunities for regulating tumor immunity","volume":"9","author":"Janji","year":"2018","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.bbcan.2025.189471_bb0910","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s12307-012-0125-8","article-title":"Shaping of NK cell responses by the tumor microenvironment","volume":"6","author":"Stojanovic","year":"2013","journal-title":"Cancer Microenviron."},{"key":"10.1016\/j.bbcan.2025.189471_bb0915","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.cyto.2019.02.001","article-title":"The role of cytokines in the regulation of NK cells in the tumor environment","volume":"117","author":"Konjevic","year":"2019","journal-title":"Cytokine"},{"key":"10.1016\/j.bbcan.2025.189471_bb0920","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.3389\/fimmu.2018.01859","article-title":"Prostaglandin E2 secreted by thyroid Cancer cells contributes to immune escape through the suppression of natural killer (NK) cell cytotoxicity and NK cell differentiation","volume":"9","author":"Park","year":"2018","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.bbcan.2025.189471_bb0925","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/j.cell.2018.10.014","article-title":"Anti-NKG2A mAb is a checkpoint inhibitor that promotes anti-tumor immunity by unleashing both T and NK cells","volume":"175","author":"Andre","year":"2018","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.bbcan.2025.189471_bb0930","doi-asserted-by":"crossref","DOI":"10.3390\/cancers9100132","article-title":"Regulation of mTOR, metabolic fitness, and effector functions by cytokines in natural killer cells","volume":"9","author":"Viel","year":"2017","journal-title":"Cancers (Basel)"},{"issue":"12","key":"10.1016\/j.bbcan.2025.189471_bb0935","doi-asserted-by":"crossref","first-page":"3934","DOI":"10.4049\/jimmunol.1701461","article-title":"Canonical TGF-beta signaling pathway represses human NK cell metabolism","volume":"200","author":"Zaiatz-Bittencourt","year":"2018","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.bbcan.2025.189471_bb0940","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1158\/2326-6066.CIR-18-0481","article-title":"Lactate-mediated acidification of tumor microenvironment induces apoptosis of liver-resident NK cells in colorectal liver metastasis","volume":"7","author":"Harmon","year":"2019","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.bbcan.2025.189471_bb0945","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3389\/fimmu.2016.00109","article-title":"A metabolic immune checkpoint: adenosine in tumor microenvironment","volume":"7","author":"Ohta","year":"2016","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2025.189471_bb0950","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.3389\/fimmu.2018.02517","article-title":"Tumor microenvironment-induced Immunometabolic reprogramming of natural killer cells","volume":"9","author":"Chambers","year":"2018","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.bbcan.2025.189471_bb0955","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1158\/0008-5472.CAN-17-2826","article-title":"A2AR adenosine signaling suppresses natural killer cell maturation in the tumor microenvironment","volume":"78","author":"Young","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2025.189471_bb0960","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.3389\/fimmu.2018.02533","article-title":"Adenosinergic signaling alters natural killer cell functional responses","volume":"9","author":"Chambers","year":"2018","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.bbcan.2025.189471_bb0965","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.cell.2013.05.016","article-title":"Posttranscriptional control of T cell effector function by aerobic glycolysis","volume":"153","author":"Chang","year":"2013","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.bbcan.2025.189471_bb0970","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.4049\/jimmunol.1202702","article-title":"Tumor-derived lactate modifies antitumor immune response: effect on myeloid-derived suppressor cells and NK cells","volume":"191","author":"Husain","year":"2013","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.bbcan.2025.189471_bb0975","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.cmet.2016.08.011","article-title":"LDHA-associated lactic acid production blunts tumor Immunosurveillance by T and NK cells","volume":"24","author":"Brand","year":"2016","journal-title":"Cell Metab."},{"issue":"3","key":"10.1016\/j.bbcan.2025.189471_bb0980","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.cmet.2022.01.007","article-title":"The hallmarks of cancer metabolism: still emerging","volume":"34","author":"Pavlova","year":"2022","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbcan.2025.189471_bb0985","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.3389\/fimmu.2019.02278","article-title":"NK cell metabolism and tumor microenvironment","volume":"10","author":"Terren","year":"2019","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.bbcan.2025.189471_bb0990","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1189\/jlb.0108024","article-title":"Glucose metabolism in lymphocytes is a regulated process with significant effects on immune cell function and survival","volume":"84","author":"Maciver","year":"2008","journal-title":"J. Leukoc. Biol."},{"issue":"11","key":"10.1016\/j.bbcan.2025.189471_bb0995","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1038\/ni.3838","article-title":"Srebp-controlled glucose metabolism is essential for NK cell functional responses","volume":"18","author":"Assmann","year":"2017","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bbcan.2025.189471_bb1000","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s13098-016-0152-6","article-title":"NK cell count and glucotransporter 4 (GLUT4) expression in subjects with type 2 diabetes and colon cancer","volume":"8","author":"Piatkiewicz","year":"2016","journal-title":"Diabetol. Metab. Syndr."},{"issue":"4","key":"10.1016\/j.bbcan.2025.189471_bb1005","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/j.1365-2362.2007.01786.x","article-title":"Glucose transporter expression on the plasma membrane of resting and activated white blood cells","volume":"37","author":"Maratou","year":"2007","journal-title":"Eur. J. Clin. Investig."},{"issue":"6","key":"10.1016\/j.bbcan.2025.189471_bb1010","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.4049\/jimmunol.1501783","article-title":"Metabolic reprogramming supports IFN-gamma production by CD56bright NK cells","volume":"196","author":"Keating","year":"2016","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbcan.2025.189471_bb1015","doi-asserted-by":"crossref","first-page":"3020","DOI":"10.3389\/fimmu.2018.03020","article-title":"Natural killer cell education is associated with a distinct glycolytic profile","volume":"9","author":"Pfeifer","year":"2018","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189471_bb1020","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.jaci.2018.06.047","article-title":"Education-dependent activation of glycolysis promotes the cytolytic potency of licensed human natural killer cells","volume":"143","author":"Schafer","year":"2019","journal-title":"J. Allergy Clin. Immunol."},{"issue":"6","key":"10.1016\/j.bbcan.2025.189471_bb1025","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.cell.2015.08.016","article-title":"Metabolic competition in the tumor microenvironment is a driver of Cancer progression","volume":"162","author":"Chang","year":"2015","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.bbcan.2025.189471_bb1030","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.cmet.2018.06.021","article-title":"Dysfunction of natural killer cells by FBP1-induced inhibition of glycolysis during lung Cancer progression","volume":"28","author":"Cong","year":"2018","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbcan.2025.189471_bb1035","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.freeradbiomed.2019.03.020","article-title":"Increased production of 27-hydroxycholesterol in human colorectal cancer advanced stage: possible contribution to cancer cell survival and infiltration","volume":"136","author":"Rossin","year":"2019","journal-title":"Free Radic. Biol. Med."},{"issue":"4","key":"10.1016\/j.bbcan.2025.189471_bb1040","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/oby.22130","article-title":"27-hydroxycholesterol inhibits sterol regulatory element-binding protein 1 activation and hepatic lipid accumulation in mice","volume":"26","author":"Li","year":"2018","journal-title":"Obesity (Silver Spring)"},{"issue":"8","key":"10.1016\/j.bbcan.2025.189471_bb1045","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1038\/s41590-018-0144-9","article-title":"The transcription factor Rfx7 limits metabolism of NK cells and promotes their maintenance and immunity","volume":"19","author":"Castro","year":"2018","journal-title":"Nat. Immunol."},{"issue":"3","key":"10.1016\/j.bbcan.2025.189471_bb1050","doi-asserted-by":"crossref","first-page":"934","DOI":"10.4049\/jimmunol.1600581","article-title":"Diacylglycerol kinase zeta is a target to enhance NK cell function","volume":"197","author":"Yang","year":"2016","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbcan.2025.189471_bb1055","doi-asserted-by":"crossref","first-page":"11154","DOI":"10.1038\/ncomms11154","article-title":"Repression of GSK3 restores NK cell cytotoxicity in AML patients","volume":"7","author":"Parameswaran","year":"2016","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.bbcan.2025.189471_bb1060","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.4049\/jimmunol.1600590","article-title":"Killer cell lectin-like receptor G1 inhibits NK cell function through activation of adenosine 5\u2019-monophosphate-activated protein kinase","volume":"197","author":"Muller-Durovic","year":"2016","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.bbcan.2025.189471_bb1065","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.smim.2016.09.001","article-title":"Nutrient sensing, signal transduction and immune responses","volume":"28","author":"Walls","year":"2016","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.bbcan.2025.189471_bb1070","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.3389\/fimmu.2020.01989","article-title":"Metabolism of natural killer cells and other innate lymphoid cells","volume":"11","author":"Cong","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2025.189471_bb1075","doi-asserted-by":"crossref","first-page":"367","DOI":"10.3389\/fimmu.2017.00367","article-title":"What fuels natural killers? Metabolism and NK cell responses","volume":"8","author":"Gardiner","year":"2017","journal-title":"Front. Immunol."},{"issue":"44","key":"10.1016\/j.bbcan.2025.189471_bb1080","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adn1849","article-title":"Metabolic programs drive function of therapeutic NK cells in hypoxic tumor environments","volume":"10","author":"Kennedy","year":"2024","journal-title":"Sci. Adv."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189471_bb1085","doi-asserted-by":"crossref","first-page":"6472","DOI":"10.1038\/s41598-021-85960-6","article-title":"Metabolic changes of Interleukin-12\/15\/18-stimulated human NK cells","volume":"11","author":"Terren","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbcan.2025.189471_bb1090","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.884648","article-title":"Cytokine-induced memory-like NK cells: from the basics to clinical applications","volume":"13","author":"Terren","year":"2022","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.bbcan.2025.189471_bb1095","doi-asserted-by":"crossref","first-page":"4477","DOI":"10.4049\/jimmunol.1401558","article-title":"mTORC1-dependent metabolic reprogramming is a prerequisite for NK cell effector function","volume":"193","author":"Donnelly","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbcan.2025.189471_bb1100","first-page":"7","article-title":"mTORC1 and mTORC2 differentially promote natural killer cell development","author":"Yang","year":"2018","journal-title":"Elife"},{"key":"10.1016\/j.bbcan.2025.189471_bb1105","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.3389\/fimmu.2019.01414","article-title":"What defines NK cell functional fate: phenotype or metabolism?","volume":"10","author":"Poznanski","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2025.189471_bb1110","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.copbio.2019.12.008","article-title":"Metabolic regulation of epigenetic remodeling in immune cells","volume":"63","author":"Britt","year":"2020","journal-title":"Curr. Opin. Biotechnol."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189471_bb1115","doi-asserted-by":"crossref","first-page":"5376","DOI":"10.1038\/s41467-021-25715-z","article-title":"Metabolic requirements of NK cells during the acute response against retroviral infection","volume":"12","author":"Littwitz-Salomon","year":"2021","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.bbcan.2025.189471_bb1120","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109210","article-title":"Lactate dehydrogenase A-dependent aerobic glycolysis promotes natural killer cell anti-viral and anti-tumor function","volume":"35","author":"Sheppard","year":"2021","journal-title":"Cell Rep."},{"issue":"12","key":"10.1016\/j.bbcan.2025.189471_bb1125","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12123542","article-title":"The tumor microenvironment-a metabolic obstacle to NK cells\u2019 activity","volume":"12","author":"Domagala","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"5","key":"10.1016\/j.bbcan.2025.189471_bb1130","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.drudis.2016.12.003","article-title":"Targeting amino ac id metabolism for cancer therapy","volume":"22","author":"Lukey","year":"2017","journal-title":"Drug Discov. Today"},{"issue":"9","key":"10.1016\/j.bbcan.2025.189471_bb1135","doi-asserted-by":"crossref","first-page":"5259","DOI":"10.4049\/jimmunol.0803523","article-title":"Regulation of NK cell function by human granulocyte arginase","volume":"182","author":"Oberlies","year":"2009","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.bbcan.2025.189471_bb1140","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.cellimm.2012.11.018","article-title":"Altered functions of natural killer cells in response to L-arginine availability","volume":"280","author":"Lamas","year":"2012","journal-title":"Cell. Immunol."},{"issue":"12","key":"10.1016\/j.bbcan.2025.189471_bb1145","doi-asserted-by":"crossref","first-page":"4644","DOI":"10.1074\/jbc.RA118.005892","article-title":"Interleukin-18 up-regulates amino acid transporters and facilitates amino acid-induced mTORC1 activation in natural killer cells","volume":"294","author":"Almutairi","year":"2019","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189471_bb1150","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1038\/s41467-018-04719-2","article-title":"Amino acid-dependent cMyc expression is essential for NK cell metabolic and functional responses in mice","volume":"9","author":"Loftus","year":"2018","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189471_bb1155","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1038\/s41467-019-10015-4","article-title":"Competition for nutrients and its role in controlling immune responses","volume":"10","author":"Kedia-Mehta","year":"2019","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189471_bb1160","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s13046-024-02994-0","article-title":"A glutamine tug-of-war between cancer and immune cells: recent advances in unraveling the ongoing battle","volume":"43","author":"Wang","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"13","key":"10.1016\/j.bbcan.2025.189471_bb1165","doi-asserted-by":"crossref","first-page":"5303","DOI":"10.1007\/s00018-021-03828-4","article-title":"Arginine-dependent immune responses","volume":"78","author":"Marti","year":"2021","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bbcan.2025.189471_bb1170","article-title":"Mitochondrial enzymes of the urea cycle cluster at the inner mitochondrial membrane","volume":"11","author":"Haskins","year":"2020","journal-title":"Front. Physiol."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189471_bb1175","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1186\/s12964-024-01760-1","article-title":"The significant role of amino acid metabolic reprogramming in cancer","volume":"22","author":"Liu","year":"2024","journal-title":"Cell Commun. Signal"},{"issue":"4","key":"10.1016\/j.bbcan.2025.189471_bb1180","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.4049\/jimmunol.1402099","article-title":"Activation-specific metabolic requirements for NK cell IFN-gamma production","volume":"194","author":"Keppel","year":"2015","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189471_bb1185","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1158\/2326-6066.CIR-16-0297","article-title":"Myeloid-derived suppressor cells","volume":"5","author":"Gabrilovich","year":"2017","journal-title":"Cancer Immunol. Res."},{"issue":"6","key":"10.1016\/j.bbcan.2025.189471_bb1190","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1002\/eji.201344272","article-title":"Effect of tumor cells and tumor microenvironment on NK-cell function","volume":"44","author":"Vitale","year":"2014","journal-title":"Eur. J. Immunol."},{"issue":"8","key":"10.1016\/j.bbcan.2025.189471_bb1195","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1158\/1078-0432.CCR-17-0691","article-title":"Nitric oxide production by myeloid-derived suppressor cells plays a role in impairing fc receptor-mediated natural killer cell function","volume":"24","author":"Stiff","year":"2018","journal-title":"Clin. Cancer Res."},{"issue":"17","key":"10.1016\/j.bbcan.2025.189471_bb1200","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.1182\/blood-2009-09-246124","article-title":"Selective inhibition of IDO1 effectively regulates mediators of antitumor immunity","volume":"115","author":"Liu","year":"2010","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.bbcan.2025.189471_bb1205","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.canlet.2011.12.020","article-title":"Hepatocellular carcinoma-associated fibroblasts trigger NK cell dysfunction via PGE2 and IDO","volume":"318","author":"Li","year":"2012","journal-title":"Cancer Lett."},{"issue":"4","key":"10.1016\/j.bbcan.2025.189471_bb1210","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1084\/jem.20020121","article-title":"Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase","volume":"196","author":"Frumento","year":"2002","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189471_bb1215","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1038\/s41467-018-04366-7","article-title":"Single cell analysis of kynurenine and system L amino acid transport in T cells","volume":"9","author":"Sinclair","year":"2018","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.bbcan.2025.189471_bb1220","doi-asserted-by":"crossref","DOI":"10.15252\/embr.202256156","article-title":"Resting natural killer cell homeostasis relies on tryptophan\/NAD(+) metabolism and HIF-1alpha","volume":"24","author":"Pelletier","year":"2023","journal-title":"EMBO Rep."},{"key":"10.1016\/j.bbcan.2025.189471_bb1225","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.3389\/fimmu.2018.01605","article-title":"Diverse roles of mitochondria in immune responses: novel insights into Immuno-metabolism","volume":"9","author":"Angajala","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2025.189471_bb1230","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217076","article-title":"Metabolic reprogramming in tumor immune microenvironment: impact on immune cell function and therapeutic implications","volume":"597","author":"Liu","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbcan.2025.189471_bb1235","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.3389\/fimmu.2020.01295","article-title":"Targeting NK cell checkpoint receptors or molecules for Cancer immunotherapy","volume":"11","author":"Zhang","year":"2020","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.bbcan.2025.189471_bb1240","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/s42255-024-01188-4","article-title":"Pivotal role of exogenous pyruvate in human natural killer cell metabolism","volume":"7","author":"Kern Coquillat","year":"2025","journal-title":"Nat. Metab."},{"issue":"11","key":"10.1016\/j.bbcan.2025.189471_bb1245","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2319254121","article-title":"Fatty acid oxidation fuels natural killer cell responses against infection and cancer","volume":"121","author":"Sheppard","year":"2024","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189471_bb1250","doi-asserted-by":"crossref","first-page":"3","DOI":"10.5045\/kjh.2011.46.1.3","article-title":"NK cell-based immunotherapy for treating cancer: will it be promising?","volume":"46","author":"Cho","year":"2011","journal-title":"Korean J Hematol"},{"issue":"9","key":"10.1016\/j.bbcan.2025.189471_bb1255","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.3109\/10428194.2012.676175","article-title":"The role of natural killer cells in immunity against multiple myeloma","volume":"53","author":"Godfrey","year":"2012","journal-title":"Leuk. Lymphoma"},{"issue":"4","key":"10.1016\/j.bbcan.2025.189471_bb1260","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/74704","article-title":"Inhibitory fc receptors modulate in vivo cytotoxicity against tumor targets","volume":"6","author":"Clynes","year":"2000","journal-title":"Nat. Med."},{"issue":"6","key":"10.1016\/j.bbcan.2025.189471_bb1265","doi-asserted-by":"crossref","first-page":"3401","DOI":"10.4049\/jimmunol.1000328","article-title":"IL-12 enhances the antitumor actions of trastuzumab via NK cell IFN-gamma production","volume":"186","author":"Jaime-Ramirez","year":"2011","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.bbcan.2025.189471_bb1270","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.173099","article-title":"IL-15 reprogramming compensates for NK cell mitochondrial dysfunction in HIV-1 infection","volume":"9","author":"Moreno-Cubero","year":"2024","journal-title":"JCI Insight"},{"issue":"10","key":"10.1016\/j.bbcan.2025.189471_bb1275","doi-asserted-by":"crossref","first-page":"4654","DOI":"10.1172\/JCI99317","article-title":"Contribution of NK cells to immunotherapy mediated by PD-1\/PD-L1 blockade","volume":"128","author":"Hsu","year":"2018","journal-title":"J. Clin. Invest."},{"issue":"5","key":"10.1016\/j.bbcan.2025.189471_bb1280","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/S1470-2045(18)30148-7","article-title":"ALT-803, an IL-15 superagonist, in combination with nivolumab in patients with metastatic non-small cell lung cancer: a non-randomised, open-label, phase 1b trial","volume":"19","author":"Wrangle","year":"2018","journal-title":"Lancet Oncol."},{"issue":"6","key":"10.1016\/j.bbcan.2025.189471_bb1285","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1158\/2159-8290.CD-18-1495","article-title":"A first-in-human study and biomarker analysis of NKTR-214, a novel IL2Rbetagamma-biased cytokine, in patients with advanced or metastatic solid tumors","volume":"9","author":"Bentebibel","year":"2019","journal-title":"Cancer Discov."},{"issue":"7","key":"10.1016\/j.bbcan.2025.189471_bb1290","doi-asserted-by":"crossref","first-page":"3571","DOI":"10.1182\/blood-2007-07-100057","article-title":"Sustained NKG2D engagement induces cross-tolerance of multiple distinct NK cell activation pathways","volume":"111","author":"Coudert","year":"2008","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189471_bb1295","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s13045-020-00896-0","article-title":"Antibody targeting tumor-derived soluble NKG2D ligand sMIC reprograms NK cell homeostatic survival and function and enhances melanoma response to PDL1 blockade therapy","volume":"13","author":"Basher","year":"2020","journal-title":"J. Hematol. Oncol."},{"issue":"12","key":"10.1016\/j.bbcan.2025.189471_bb1300","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1249\/MSS.0000000000003250","article-title":"Acute exercise increases NK cell mitochondrial respiration and cytotoxicity against triple-negative breast Cancer cells under hypoxic conditions","volume":"55","author":"Cho","year":"2023","journal-title":"Med. Sci. Sports Exerc."},{"issue":"8","key":"10.1016\/j.bbcan.2025.189471_bb1305","doi-asserted-by":"crossref","DOI":"10.3390\/cells8080795","article-title":"Mitochondrial uncoupling: a key controller of biological processes in physiology and diseases","volume":"8","author":"Demine","year":"2019","journal-title":"Cells"},{"issue":"11","key":"10.1016\/j.bbcan.2025.189471_bb1310","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s00018-022-04595-6","article-title":"Mfn2-mediated mitochondrial fusion promotes autophagy and suppresses ovarian cancer progression by reducing ROS through AMPK\/mTOR\/ERK signaling","volume":"79","author":"Ashraf","year":"2022","journal-title":"Cell. Mol. Life Sci."},{"issue":"8","key":"10.1016\/j.bbcan.2025.189471_bb1315","article-title":"Combination of dual mTORC1\/2 inhibition and immune-checkpoint blockade potentiates anti-tumour immunity","volume":"7","author":"Langdon","year":"2018","journal-title":"Oncoimmunology"},{"issue":"20","key":"10.1016\/j.bbcan.2025.189471_bb1320","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14205046","article-title":"Immune checkpoint blockade: a strategy to unleash the potential of natural killer cells in the anti-Cancer therapy","volume":"14","author":"Grottoli","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"5","key":"10.1016\/j.bbcan.2025.189471_bb1325","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1111\/j.1365-2141.2009.07667.x","article-title":"Replicative potential of human natural killer cells","volume":"145","author":"Fujisaki","year":"2009","journal-title":"Br. J. Haematol."},{"issue":"7229","key":"10.1016\/j.bbcan.2025.189471_bb1330","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/nature07665","article-title":"Adaptive immune features of natural killer cells","volume":"457","author":"Sun","year":"2009","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.bbcan.2025.189471_bb1335","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1002\/eji.201445200","article-title":"IL-12\/15\/18-preactivated NK cells suppress GvHD in a mouse model of mismatched hematopoietic cell transplantation","volume":"45","author":"Huber","year":"2015","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.bbcan.2025.189471_bb1340","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.smim.2017.07.011","article-title":"Natural killer cells unleashed: checkpoint receptor blockade and BiKE\/TriKE utilization in NK-mediated anti-tumor immunotherapy","volume":"31","author":"Davis","year":"2017","journal-title":"Semin. Immunol."},{"issue":"7","key":"10.1016\/j.bbcan.2025.189471_bb1345","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1111\/jcmm.12810","article-title":"CD19-CAR engineered NK-92 cells are sufficient to overcome NK cell resistance in B-cell malignancies","volume":"20","author":"Romanski","year":"2016","journal-title":"J. Cell. Mol. Med."},{"issue":"21","key":"10.1016\/j.bbcan.2025.189471_bb1350","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1182\/blood.2020006200","article-title":"CD38 deletion of human primary NK cells eliminates daratumumab-induced fratricide and boosts their effector activity","volume":"136","author":"Naeimi Kararoudi","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.bbcan.2025.189471_bb1355","first-page":"1553","article-title":"Enhanced NK cell adoptive antitumor effects against breast cancer in vitro via blockade of the transforming growth factor-beta signaling pathway","volume":"8","author":"Zhao","year":"2015","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.bbcan.2025.189471_bb1360","article-title":"Effect of CRISPR\/Cas9-edited PD-1\/PD-L1 on tumor immunity and immunotherapy","volume":"13","author":"Xu","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2025.189471_bb1365","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.omtm.2023.03.006","article-title":"Simultaneous engineering of natural killer cells for CAR transgenesis and CRISPR-Cas9 knockout using retroviral particles","volume":"29","author":"Jo","year":"2023","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189471_bb1370","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/s13046-023-02770-6","article-title":"CIS deletion by CRISPR\/Cas9 enhances human primary natural killer cell functions against allogeneic glioblastoma","volume":"42","author":"Nakazawa","year":"2023","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189471_bb1375","doi-asserted-by":"crossref","first-page":"2081415","DOI":"10.1080\/2162402X.2022.2081415","article-title":"CRISPR-Cas9 based gene editing of the immune checkpoint NKG2A enhances NK cell mediated cytotoxicity against multiple myeloma","volume":"11","author":"Bexte","year":"2022","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.bbcan.2025.189471_bb1380","article-title":"Effective anti-tumor response by TIGIT blockade associated with FcgammaR engagement and myeloid cell activation","volume":"11","author":"Han","year":"2020","journal-title":"Front. Immunol."},{"issue":"12","key":"10.1016\/j.bbcan.2025.189471_bb1385","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-007502","article-title":"Knockout of the inhibitory receptor TIGIT enhances the antitumor response of ex vivo expanded NK cells and prevents fratricide with therapeutic fc-active TIGIT antibodies","volume":"11","author":"Hasan","year":"2023","journal-title":"J. Immunother. Cancer"},{"issue":"2","key":"10.1016\/j.bbcan.2025.189471_bb1390","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.stem.2020.05.008","article-title":"Metabolic reprograming via deletion of CISH in human iPSC-derived NK cells promotes in vivo persistence and enhances anti-tumor activity","volume":"27","author":"Zhu","year":"2020","journal-title":"Cell Stem Cell"},{"issue":"2","key":"10.1016\/j.bbcan.2025.189471_bb1395","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2016.1267892","article-title":"Targeting cytokine signaling checkpoint CIS activates NK cells to protect from tumor initiation and metastasis","volume":"6","author":"Putz","year":"2017","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.bbcan.2025.189471_bb1400","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.834002","article-title":"CRISPR gene editing of human primary NK and T cells for Cancer immunotherapy","volume":"12","author":"Elmas","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbcan.2025.189471_bb1405","doi-asserted-by":"crossref","first-page":"1550652","DOI":"10.3389\/fimmu.2025.1550652","article-title":"Novel strategies to overcome tumor immunotherapy resistance using CAR NK cells","volume":"16","author":"Guo","year":"2025","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189471_bb1410","doi-asserted-by":"crossref","first-page":"8439","DOI":"10.1038\/s41467-024-52388-1","article-title":"CRISPR\/Cas9 editing of NKG2A improves the efficacy of primary CD33-directed chimeric antigen receptor natural killer cells","volume":"15","author":"Bexte","year":"2024","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.bbcan.2025.189471_bb1415","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/bjh.14866","article-title":"Activity of lenalidomide in mantle cell lymphoma can be explained by NK cell-mediated cytotoxicity","volume":"179","author":"Hagner","year":"2017","journal-title":"Br. J. Haematol."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189471_bb1420","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/s41375-020-0809-x","article-title":"Immunomodulatory drugs activate NK cells via both Zap-70 and cereblon-dependent pathways","volume":"35","author":"Hideshima","year":"2021","journal-title":"Leukemia"},{"key":"10.1016\/j.bbcan.2025.189471_bb1425","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.3389\/fimmu.2018.02140","article-title":"Avelumab, an IgG1 anti-PD-L1 immune checkpoint inhibitor, triggers NK cell-mediated cytotoxicity and cytokine production against triple negative breast Cancer cells","volume":"9","author":"Julia","year":"2018","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189471_bb1430","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001933","article-title":"Expanded human NK cells from lung cancer patients sensitize patients\u2019 PDL1-negative tumors to PD1-blockade therapy","volume":"9","author":"Poznanski","year":"2021","journal-title":"J. Immunother. Cancer"},{"issue":"15","key":"10.1016\/j.bbcan.2025.189471_bb1435","doi-asserted-by":"crossref","first-page":"4107","DOI":"10.1158\/1078-0432.CCR-16-2981","article-title":"Successful transfer of umbilical cord blood CD34(+) hematopoietic stem and progenitor-derived NK cells in older acute myeloid leukemia patients","volume":"23","author":"Dolstra","year":"2017","journal-title":"Clin. Cancer Res."},{"issue":"8","key":"10.1016\/j.bbcan.2025.189471_bb1440","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1093\/neuonc\/noaa047","article-title":"Phase I study of intraventricular infusions of autologous ex vivo expanded NK cells in children with recurrent medulloblastoma and ependymoma","volume":"22","author":"Khatua","year":"2020","journal-title":"Neuro-Oncology"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189471_bb1445","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3109\/14653249.2010.515582","article-title":"A phase II study of allogeneic natural killer cell therapy to treat patients with recurrent ovarian and breast cancer","volume":"13","author":"Geller","year":"2011","journal-title":"Cytotherapy"},{"issue":"6","key":"10.1016\/j.bbcan.2025.189471_bb1450","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1056\/NEJMoa1910607","article-title":"Use of CAR-transduced natural killer cells in CD19-positive lymphoid tumors","volume":"382","author":"Liu","year":"2020","journal-title":"N. Engl. J. Med."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X25002136?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X25002136?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T04:23:23Z","timestamp":1781065403000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304419X25002136"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":290,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S0304419X25002136"],"URL":"https:\/\/doi.org\/10.1016\/j.bbcan.2025.189471","relation":{},"ISSN":["0304-419X"],"issn-type":[{"value":"0304-419X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mitochondrial dynamics and metabolic attributes regulate function of natural killer cell and infiltration in tumor microenvironment modulating disease progression","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbcan.2025.189471","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"189471"}}